Drug Development and Translational Research of Dual VEGFR and FGFR Tyrosine Kinase Inhibitor, Lenvatinib with Type V Kinase Binding Mode as an Anti-cancer Drug
Year: 2019
Type: conference-abstract
Source: The Japanese Biochemical Society
Author: Junji Matsui
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3195038512
